Skip to main content

BioNTech shares slip on gloomy Covid vaccine sales outlook

The shares initially fell by 6.4% to an intraday low of $119.98 a share before recovering most of those losses in late morning trading.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.